Use of levosimendan combined with Shenfu injection to treat acute heart failure patients with hypotension: a prospective randomized controlled single-blind study

BACKGROUND: Levosimendan can improve clinical symptoms and the cardiorenal rescue success rate, and stabilize hemodynamic parameters in individuals suffering from acute decompensated heart failure. In addition, Shenfu injection (SFI) has been shown to protect the ischemic heart and enhance myocardia...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Miaomiao, Zhang, Yue, Wan, Qianli, Li, Yiou, Qu, Tianzhen, Yuan, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966164/
https://www.ncbi.nlm.nih.gov/pubmed/35350988
http://dx.doi.org/10.1186/s12872-022-02572-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966164/
https://www.ncbi.nlm.nih.gov/pubmed/35350988
http://dx.doi.org/10.1186/s12872-022-02572-2

Ejemplares similares